BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15172630)

  • 41. [LDL-apheresis in Sardinia, Italy].
    Pintus P
    G Ital Nefrol; 2012; 29 Suppl 54():S19-21. PubMed ID: 22388824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [LDL-apheresis in the treatment familial hypercholesterolemia].
    Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
    Vnitr Lek; 2014 Nov; 60(11):970-6. PubMed ID: 25600044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-density lipoprotein apheresis: an overview.
    Bambauer R; Schiel R; Latza R
    Ther Apher Dial; 2003 Aug; 7(4):382-90. PubMed ID: 12887719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of plasmapheresis, cascade-filtration and dextran-sulfate adsorption apheresis with calculation of the recovery rate of lipids and lipoproteins.
    Schwartzkopff W; Nold A; Gräfenhahn H; von Baeyer H; Schwerdtfeger R
    Beitr Infusionsther; 1988; 23():103-11. PubMed ID: 2484763
    [No Abstract]   [Full Text] [Related]  

  • 46. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001.
    Krebs A; Krebs K; Keller F
    Int J Artif Organs; 2004 Feb; 27(2):137-48. PubMed ID: 15061475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
    Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
    Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
    [No Abstract]   [Full Text] [Related]  

  • 48. [LDL-apheresis--clinical indication and utility].
    Nakamura T; Ishikawa K
    Nihon Rinsho; 1999 Dec; 57(12):2854-61. PubMed ID: 10638225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative ultrastructural study of platelet plasma-membrane in hypercholesterolemic type IIa patients after plasma exchange and LDL-apheresis.
    Bianciardi G; Gnasso A; Postiglione A; Scarpato N; Tanganelli P; Weber G
    Beitr Infusionsther; 1988; 23():183-8. PubMed ID: 2484775
    [No Abstract]   [Full Text] [Related]  

  • 50. Hypercholesterolemia and LDL apheresis.
    Morelli F; Carlier P; Giannini G; De Luigi MC; Dejana AM; Ruzzenenti MR
    Int J Artif Organs; 2005 Oct; 28(10):1025-31. PubMed ID: 16288441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Double membrane filtration in LDL-apheresis].
    Yamamoto A; Kojima S
    Nihon Rinsho; 1992 Jan; 50 Suppl():374-81. PubMed ID: 1578710
    [No Abstract]   [Full Text] [Related]  

  • 52. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids].
    Loschiavo C
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma exchange and LDL apheresis.
    Thompson GR; Okabayashi K
    Prog Clin Biol Res; 1988; 255():311-6. PubMed ID: 3277202
    [No Abstract]   [Full Text] [Related]  

  • 55. [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].
    Konovalov GA; Kukharchuk VV; Sinitsin VV; Trakht IN; Adamova IIu
    Vutr Boles; 1989; 28(4):133-6. PubMed ID: 2596087
    [No Abstract]   [Full Text] [Related]  

  • 56. [Influence of the primary membrane on lipid apheresis selectivity in cascade filtration].
    Legallais C; Morinière P; Jaffrin M; Lalau JD
    Ann Med Interne (Paris); 1994; 145(5):333-6. PubMed ID: 7985943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
    Ramunni A; Quaranta N; Saliani MT; Fallacara RA; Ria R; Ranieri G
    Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.
    Makino H; Harada-Shiba M
    Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mobilisation of tissue cholesterol by apheresis.
    Thompson GR
    Prog Clin Biol Res; 1990; 337():183-7. PubMed ID: 2191311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.